| UniProt ID | AL1L2_HUMAN | |
|---|---|---|
| UniProt AC | Q3SY69 | |
| Protein Name | Mitochondrial 10-formyltetrahydrofolate dehydrogenase | |
| Gene Name | ALDH1L2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 923 | |
| Subcellular Localization | Mitochondrion . | |
| Protein Description | ||
| Protein Sequence | MLRRGSQALRRFSTGRVYFKNKLKLALIGQSLFGQEVYSHLRKEGHRVVGVFTVPDKDGKADPLALAAEKDGTPVFKLPKWRVKGKTIKEVAEAYRSVGAELNVLPFCTQFIPMDIIDSPKHGSIIYHPSILPRHRGASAINWTLIMGDKKAGFSVFWADDGLDTGPILLQRSCDVEPNDTVDALYNRFLFPEGIKAMVEAVQLIADGKAPRIPQPEEGATYEGIQKKENAEISWDQSAEVLHNWIRGHDKVPGAWTEINGQMVTFYGSTLLNSSVPPGEPLEIKGAKKPGLVTKNGLVLFGNDGKALTVRNLQFEDGKMIPASQYFSTGETSVVELTAEEVKVAETIKVIWAGILSNVPIIEDSTDFFKSGASSMDVARLVEEIRQKCGGLQLQNEDVYMATKFEGFIQKVVRKLRGEDQEVELVVDYISKEVNEIMVKMPYQCFINGQFTDADDGKTYDTINPTDGSTICKVSYASLADVDKAVAAAKDAFENGEWGRMNARERGRLMYRLADLLEENQEELATIEALDSGAVYTLALKTHIGMSVQTFRYFAGWCDKIQGSTIPINQARPNRNLTFTKKEPLGVCAIIIPWNYPLMMLAWKSAACLAAGNTLVLKPAQVTPLTALKFAELSVKAGFPKGVINIIPGSGGIAGQRLSEHPDIRKLGFTGSTPIGKQIMKSCAVSNLKKVSLELGGKSPLIIFNDCELDKAVRMGMGAVFFNKGENCIAAGRLFVEESIHDEFVTRVVEEIKKMKIGDPLDRSTDHGPQNHKAHLEKLLQYCETGVKEGATLVYGGRQVQRPGFFMEPTVFTDVEDYMYLAKEESFGPIMVISKFQNGDIDGVLQRANSTEYGLASGVFTRDINKAMYVSEKLEAGTVFINTYNKTDVAAPFGGVKQSGFGKDLGEEALNEYLKTKTVTLEY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 31 | Phosphorylation | KLALIGQSLFGQEVY HHHHEEHHHHCHHHH | 22.06 | - | |
| 57 | Acetylation | GVFTVPDKDGKADPL EEEEECCCCCCCCHH | 63.41 | 66702447 | |
| 57 | Malonylation | GVFTVPDKDGKADPL EEEEECCCCCCCCHH | 63.41 | 26320211 | |
| 60 | Succinylation | TVPDKDGKADPLALA EECCCCCCCCHHHHH | 60.80 | - | |
| 60 | Acetylation | TVPDKDGKADPLALA EECCCCCCCCHHHHH | 60.80 | 26051181 | |
| 60 | Malonylation | TVPDKDGKADPLALA EECCCCCCCCHHHHH | 60.80 | 26320211 | |
| 70 | Malonylation | PLALAAEKDGTPVFK HHHHHCCCCCCCCCC | 57.65 | 26320211 | |
| 70 | Acetylation | PLALAAEKDGTPVFK HHHHHCCCCCCCCCC | 57.65 | 23236377 | |
| 77 | Acetylation | KDGTPVFKLPKWRVK CCCCCCCCCCCCEEC | 65.20 | 19822193 | |
| 89 | Ubiquitination | RVKGKTIKEVAEAYR EECCCCHHHHHHHHH | 51.90 | - | |
| 89 | Malonylation | RVKGKTIKEVAEAYR EECCCCHHHHHHHHH | 51.90 | 26320211 | |
| 109 | Phosphorylation | LNVLPFCTQFIPMDI HCCCCCCCCCCCCCC | 27.22 | 46161977 | |
| 124 | Phosphorylation | IDSPKHGSIIYHPSI CCCCCCCCEEECCCC | 12.92 | 69003655 | |
| 127 | Phosphorylation | PKHGSIIYHPSILPR CCCCCEEECCCCCCC | 13.15 | 69004527 | |
| 209 | Malonylation | VQLIADGKAPRIPQP HHHHHCCCCCCCCCC | 56.62 | 26320211 | |
| 222 | Phosphorylation | QPEEGATYEGIQKKE CCCCCCCCCCCCHHH | 16.18 | - | |
| 227 | Acetylation | ATYEGIQKKENAEIS CCCCCCCHHHCCCCC | 61.20 | 23236377 | |
| 270 | Phosphorylation | MVTFYGSTLLNSSVP EEEEECCEECCCCCC | 30.79 | 46161983 | |
| 295 | Malonylation | KKPGLVTKNGLVLFG CCCCEEECCCEEEEC | 41.35 | 26320211 | |
| 338 | Phosphorylation | ETSVVELTAEEVKVA CCEEEEEEHHHHHHH | 20.65 | 46161989 | |
| 371 | Phosphorylation | DSTDFFKSGASSMDV CCCHHHHCCCCHHHH | 34.14 | 24670416 | |
| 375 | O-(pantetheine 4'-phosphoryl)serine | FFKSGASSMDVARLV HHHCCCCHHHHHHHH | 20.61 | - | |
| 375 | Phosphorylation | FFKSGASSMDVARLV HHHCCCCHHHHHHHH | 20.61 | 24670416 | |
| 411 | Malonylation | KFEGFIQKVVRKLRG HHHHHHHHHHHHHCC | 37.57 | 26320211 | |
| 484 | Malonylation | ASLADVDKAVAAAKD CCHHHHHHHHHHHHH | 44.61 | 26320211 | |
| 490 | Malonylation | DKAVAAAKDAFENGE HHHHHHHHHHHHCCC | 44.88 | 26320211 | |
| 550 | Phosphorylation | HIGMSVQTFRYFAGW CCCCCHHHHHHHHHH | 14.13 | 46161995 | |
| 560 | Malonylation | YFAGWCDKIQGSTIP HHHHHHHHCCCCEEC | 33.52 | 26320211 | |
| 623 | Phosphorylation | VLKPAQVTPLTALKF EECCCCCCHHHHHHH | 10.66 | 22210691 | |
| 626 | Phosphorylation | PAQVTPLTALKFAEL CCCCCHHHHHHHHHH | 31.02 | 22210691 | |
| 636 | Malonylation | KFAELSVKAGFPKGV HHHHHHHHCCCCCCC | 39.14 | 26320211 | |
| 650 | Phosphorylation | VINIIPGSGGIAGQR CEEECCCCCCCCCCC | 28.61 | - | |
| 670 | Phosphorylation | DIRKLGFTGSTPIGK CHHHCCCCCCCHHHH | 28.55 | 46162001 | |
| 681 | Succinylation | PIGKQIMKSCAVSNL HHHHHHHHHHHHCCC | 43.97 | - | |
| 681 | Malonylation | PIGKQIMKSCAVSNL HHHHHHHHHHHHCCC | 43.97 | 26320211 | |
| 681 | Succinylation | PIGKQIMKSCAVSNL HHHHHHHHHHHHCCC | 43.97 | - | |
| 754 | Acetylation | RVVEEIKKMKIGDPL HHHHHHHHCCCCCCC | 51.60 | 30586859 | |
| 756 | Malonylation | VEEIKKMKIGDPLDR HHHHHHCCCCCCCCC | 53.03 | 26320211 | |
| 765 | Phosphorylation | GDPLDRSTDHGPQNH CCCCCCCCCCCCHHH | 32.67 | 29460479 | |
| 778 | Malonylation | NHKAHLEKLLQYCET HHHHHHHHHHHHHHH | 61.94 | 26320211 | |
| 788 | Succinylation | QYCETGVKEGATLVY HHHHHCCCCCCEEEE | 52.34 | - | |
| 788 | Malonylation | QYCETGVKEGATLVY HHHHHCCCCCCEEEE | 52.34 | 26320211 | |
| 886 | Malonylation | VFINTYNKTDVAAPF EEEEECCCCCCCCCC | 35.37 | 26320211 | |
| 886 | Acetylation | VFINTYNKTDVAAPF EEEEECCCCCCCCCC | 35.37 | 19608861 | |
| 897 | Malonylation | AAPFGGVKQSGFGKD CCCCCCCCCCCCCCC | 41.86 | 26320211 | |
| 903 | Malonylation | VKQSGFGKDLGEEAL CCCCCCCCCCCHHHH | 47.74 | 26320211 | |
| 903 | Acetylation | VKQSGFGKDLGEEAL CCCCCCCCCCCHHHH | 47.74 | 19608861 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AL1L2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AL1L2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AL1L2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MYCB2_HUMAN | MYCBP2 | physical | 26186194 | |
| TTC5_HUMAN | TTC5 | physical | 26186194 | |
| TBA1A_HUMAN | TUBA1A | physical | 26186194 | |
| SGT1_HUMAN | SUGT1 | physical | 26186194 | |
| WDR11_HUMAN | WDR11 | physical | 26186194 | |
| DPOLA_HUMAN | POLA1 | physical | 26186194 | |
| INT14_HUMAN | VWA9 | physical | 26186194 | |
| SGT1_HUMAN | SUGT1 | physical | 28514442 | |
| WDR11_HUMAN | WDR11 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-903, AND MASS SPECTROMETRY. | |